Strategic Expansion Details

Tavexia Lifecare Limited has expanded into the pharmaceutical business as an additional growth vertical while maintaining its existing lifecare business as the core operations. The expansion is part of the company's growth and diversification strategy to strengthen its presence in the healthcare and lifecare ecosystem.

Operational Scope

The company plans to explore opportunities across the entire pharmaceutical value chain, including:

  • Pharmaceutical products
  • Active pharmaceutical ingredients (APIs)
  • Intermediates
  • Specialty chemicals
  • Nutraceuticals
  • Related manufacturing opportunities

Market Context and Rationale

The expansion coincides with strong growth in India's pharmaceutical sector. The Indian pharmaceutical market is currently valued at approximately US$60 billion and is projected to reach US$130 billion by 2030. India's pharmaceutical exports reached US$30.47 billion in FY2024-25, highlighting the country's growing importance in global healthcare supply chains.

Management Commentary

Mr. Mit Tarunkumar Brahmbhatt, Chairman and Managing Director, stated: "Our core lifecare business remains central to Tavexia's growth journey, and the addition of pharmaceuticals is a natural extension of our presence in the broader healthcare ecosystem. India's pharmaceutical sector presents significant opportunities, and we see potential to build an additional growth engine alongside our existing operations. Our focus will remain on disciplined execution, developing sustainable business capabilities and creating long-term value for our shareholders and stakeholders."

Future Strategy

The company will continue focusing on strengthening existing lifecare operations while evaluating pharmaceutical opportunities based on market potential, commercial viability, and long-term strategic value. The pharmaceutical vertical is expected to broaden Tavexia's addressable market and provide a more diversified platform for future growth.

Expected Impact

The addition of the pharmaceutical vertical is intended to complement existing lifecare operations, provide additional avenues for business expansion, diversify revenue base, and leverage broader growth of India's healthcare sector. The company believes this move can create greater opportunities for partnerships, product development, and long-term business growth.